Search
27 Jan 2026
Search
27 Jan 2026
Please allow ads as they help fund our trusted local news content.
Kindly add us to your ad blocker whitelist.
If you want further access to Ireland's best local journalism, consider contributing and/or subscribing to our free daily Newsletter .
Support our mission and join our community now.
To continue reading this article, you can subscribe for as little as €0.50 per week which will also give you access to all of our premium content and archived articles!
Alternatively, you can pay €0.50 per article, capped at €1 per day.
Thank you for supporting Ireland's best local journalism!
Clonmel, Co Tipperary and Cambridge, Massachusetts-based Shorla Oncology has announced that it has secured $21 million (€18 million) in its latest round of funding.
This recent investment follows a very successful funding round in 2023 and now brings their total fundraising to date to over $60 million.
The Tipperary-business has gone from strength to strength in recent years, with founders Sharon Cunningham and Orlaith Ryan also claiming the prestigious title of overall winners at the EY Entrepreneur of the Year award in 2024.
Shorla Oncology is an Irish-American pharmaceutical company focused on developing treatments for rare cancers, particularly in paediatric oncology.
READ NEXT: Gym company in Limerick looking to expand into Tipp with gym and padel facilities
Founded in 2018, the company is dually headquartered in Clonmel, Co Tipperary and Cambridge, Massachusetts, reflecting its Irish roots and strong US growth trajectory.
Shorla’s mission, delivering new options for patients in areas of oncology long overlooked by big pharma, continues to resonate across both sides of the Atlantic.
Subscribe or register today to discover more from DonegalLive.ie
Buy the e-paper of the Donegal Democrat, Donegal People's Press, Donegal Post and Inish Times here for instant access to Donegal's premier news titles.
Keep up with the latest news from Donegal with our daily newsletter featuring the most important stories of the day delivered to your inbox every evening at 5pm.
This publication supports the work of the Press Council of Ireland and Office of the Press Ombudsman, and our staff operate within the Code of Practice of the Press Council. You can obtain a copy of the Code, or contact the Council, at www.presscouncil.ie, Lo-call 1800 208 080 or email: info@presscouncil.ie.
